Lotus Eye Hospital And Institute Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2025 ,inter alia, to consider and approve Unaudited ....
LOTUSEYE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Lotus Eye Hospital And Institute Ltd has informed BSE that its Board of Directors will meet on Wednesday, November 12, 2025. The key item on the agenda is to consider and approve the Unaudited Standalone Financial Results for the quarter and half-year ended September 30, 2025. This is a standard regulatory disclosure under SEBI LODR Regulation 29, and no specific financial figures or business updates have been shared in this filing. The insider trading window, which was closed ahead of the results, will reopen from November 15, 2025.
This is a routine advance notice with no immediate impact on the stock price. Retail investors should track the actual Q2/H1 FY26 results announcement on November 12, 2025 for any material updates on revenue, profitability, and outlook.